已核实 DOI 相关产品: 121

A Smart Glutathione and H2O2 Dual-Responsive Signal Inversion Magnetic Resonance Imaging Contrast Agent for Tumor Diagnosis

Journal 2021 · IF 1.134 · 发表于 2021 年 8 月 2 日
作者: Zi-Hou LI,Kun QIAN,Akakuru Ozioma-Udochukwu,Chun-Shu PAN,Xue-Hua MA,Ying-Ying HAN,Jian-Jun ZHENG,Ping CUI,Gang WEI,Zhe-Yu SHEN,Ai-Guo WU
阅读全文 在 PubMed 查看

摘要

Accurate bioimaging of internal body tissues plays a key role in achieving precise medical diagnosis. Magnetic resonance imaging (MRI) as one of the clinically used bioimaging modalities is largely hampered by the occurrence of false-positive imaging (artifacts). The use of contrast agents has tremendously contributed to the improvement of the accuracy of MRI, however, developing a dual-responsive contrast agent that capable of effectively switching from T 2 to T 1 contrast enhancement in vivo still remains a challenge. Here, we demonstrated the synthesis of a glutathione (GSH) and H 2 O 2 dual-responsive “signal inversion” contrast agent, which mainly comprised of superparamagnetic iron oxide nanoparticles (SPION) and degradable mesoporous silica nanoparticles (DMSN). The contrast agent achieved T 2 -weighted imaging in tumor site, and enabled an efficacious switch to T 1 -weighted imaging upon the GSH- and H 2 O 2 -mediated degradation of DMSN. The characteristics of the signal transformation largely reduced the artifacts to enhance the accuracy of MRI. Interestingly, the in vivo evaluations revealed prominence of the T 2 -weighted imaging up to 2 h post-intravenous injection, which was succeeded by T 1 -weighted imaging that gradually increased with time and became dominant after 24 h. It was therefore expected that the findings shown in this work would guide the development of other contrast agents alike for more robust and accurate bioimaging by using MRI.

本研究中使用的阿拉丁产品

121 款产品在本文中被引用